NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 238 filers reported holding NEOGENOMICS INC in Q1 2019. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $100,000 | +733.3% | 12,261 | +4441.1% | 0.00% | – |
| Q2 2021 | $12,000 | -73.9% | 270 | -68.1% | 0.00% | -100.0% |
| Q4 2020 | $46,000 | +4500.0% | 846 | +1358.6% | 0.00% | – |
| Q3 2019 | $1,000 | -98.9% | 58 | -98.7% | 0.00% | -100.0% |
| Q1 2019 | $91,000 | +2175.0% | 4,456 | +1361.0% | 0.04% | +1700.0% |
| Q4 2018 | $4,000 | -63.6% | 305 | -57.4% | 0.00% | -50.0% |
| Q3 2018 | $11,000 | – | 716 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |